DENORA2024-04-012024-06-30 DENORA2024-04-012024-06-30in-bse-fin:OneOperatingExpenses01Member DENORA2024-06-30 DENORA2024-04-012024-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member DENORA2024-04-012024-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 590031 DENORA NOTLISTED De Nora India Limited Equity 2024-04-01 2025-03-31 2024-07-26 2024-07-18 INR Lakhs First quarter 14:30:00 15:40:00 2024-07-26 2024-07-26 Not applicable Single segment Electrode Technologies 2024-04-01 2024-06-30 Unaudited Standalone 127582000.00 13427000.00 141009000.00 44826000.00 0.00 -13526000.00 15456000.00 0.00 3958000.00 51490000.00 102204000.00 38805000.00 0.00 38805000.00 9733000.00 254000.00 9987000.00 0.00 28818000.00 0.00 0.00 0.00 0.00 28818000.00 43000.00 28861000.00 0.00 0.00 53086000.00 10 5.43 5.43 0.00 0.00 5.43 5.43 Notes 1 The above statement of unaudited financial results for quarter ended june 30,2024 have been subjected to Limited Review by the statutory auditors of the Company in terms of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015, as amended and have been reviewed by the Audit Committee and approved by the Board of Directors at its meeting held on July 26, 2024. 2 The Statement of unaudited financial results for the quarter ended June 30, 2024 has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 Interim Financial Reporting (IND AS 34), prescribed under Section 133 of the Companies Act, 2013, and other accounting principles. 3 The Chief Operating Decision Maker (CODM) has determined that Electrode Technologies is the sole reportable segment in compliance with Ind AS 108 - Operating Segments, and thus, no segment information has been disclosed. 4 The figures for the quarter ended March 31, 2024 are balancing figures between the audited figures in respect of full previous financial year and the published unaudited year to date figures for the nine months period ended December 31, 2023. Other Expenses 51490000.00 Changes in fair value of FVTOCI equity securities 112000.00 Remeasurement of post employment benefit obligations -93000.00 19000.00 -24000.00 0.00